U.S. vaping-related deaths rise to 54, hospitalizations to 2,506

This post was originally published on this site

© Reuters. A man uses a Juul vaporizer in Atlanta© Reuters. A man uses a Juul vaporizer in Atlanta

(Reuters) – U.S. health officials said on Thursday two more deaths occurred since last week from a mysterious respiratory illness tied to vaping, taking the total toll to 54.

The Centers for Disease Control and Prevention (CDC) also reported 97 more hospitalized cases from 50 states, the District of Columbia, and two U.S. territories, as of Dec. 17. The number of people hospitalized now stands at 2,506.

The deaths have been confirmed in 27 states and the District of Columbia, and the CDC said more deaths are under investigation.

U.S. officials in November reported the discovery of Vitamin E acetate — believed to be used as a cutting agent in illicit vaping products containing marijuana components — in all lung samples from 29 patients.

CDC has called Vitamin E acetate as a “chemical of concern” and recommended the substance not be added to e-cigarette, or vaping products, while the investigation is ongoing.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Add Comment